Cochrane · systematic review · CD012451

Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non‐cardiac surgery

Kaufner, L, von Heymann, C, Henkelmann, A, et al. · Cochrane Database of Systematic Reviews · 2020 · Cochrane Library

AnaesthesiaAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 3 · 42.9%Moderate 4 · 57.1%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

rHuEPO with iron compared to control treatment with or without iron in preoperative anaemic adults undergoing non‐cardiac surgery

Population: adult participants, irrespective of gender and type of non‐cardiac surgery, with mild or severe preoperative anaemia
7 questions
OutcomeEffectEvidenceStatus / GRADE
Transfusion (measured in participants during or up to 5 days after operation)
rHuEPO with iron vs control treatment with or without iron
RR 0.55 [0.38, 0.8]12 studies · 1880 participantsModerate
Downgraded: inconsistency
Subgroup Hb concentration immediately prior to surgery (g/dL) rHuEPO high (500 to 600 IU/kg BW)
rHuEPO with iron vs control treatment with or without iron
no estimate extracted3 studies · 852 participantsLow
Downgraded: risk of bias, inconsistency
Subgroup Hb concentration immediately prior to surgery (g/dL) rHuEPO low (150 to 300 IU/kg BW)
rHuEPO with iron vs control treatment with or without iron
no estimate extracted4 studies · 334 participantsLow
Downgraded: risk of bias, inconsistency
Number of RBC units transfused per participant (intraoperative to 5 days postoperative)
rHuEPO with iron vs control treatment with or without iron
no estimate extracted6 studies · 1420 participantsModerate
Downgraded: imprecision
Mortality (within 30 days after surgery)
rHuEPO with iron vs control treatment with or without iron
RR 1.18 [0.39, 3.63]2 studies · 230 participantsModerate
Downgraded: imprecision
Adverse events (number of participants with any adverse event)
rHuEPO with iron vs control treatment with or without iron
RR 0.93 [0.68, 1.28]10 studies · 1722 participantsModerate
Downgraded: imprecision
Length of hospital stay
rHuEPO with iron vs control treatment with or without iron
no estimate extracted3 studies · 293 participantsLow
Downgraded: imprecision, inconsistency